Navigation Links
Gene therapy corrects sickle cell disease in laboratory study
Date:12/3/2008

Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology. In their studies, the researchers found that the treated mice showed essentially no difference from normal mice. Although the scientists caution that applying the gene therapy to humans presents significant technical obstacles, they believe that the new therapy will become an important treatment for the disease.

Sickle cell disease, which affects millions of people worldwide, arises because of a tiny genetic defect in the gene for beta-globin, a protein component of hemoglobin. This defect causes hemoglobin-containing red blood cells to tend to deform, clump and break apart. The resulting clogged blood vessels can lead to cognitive dysfunction by causing small strokes in the brain and cause damage to kidneys, liver, spleen and lungs. The only permanent cure for the disease is a bone marrow transplant to give recipients blood-forming cells that will form normal beta-globin. However, such transplants are rare because of the lack of compatible donors.

Researchers have long known that symptoms of the disease could be alleviated by persistence in the blood of an immature fetal form of hemoglobin in red blood cells. This immature hemoglobin, which usually disappears after birth, does not contain beta-globin, but another form called gamma-globin. St. Jude researchers had found that treating patients with the drug hydroxyurea encourages the formation of fetal hemoglobin and alleviates disease symptoms.

"While this is a very useful treatment for the disease, our studies indicated that it might be possible to cure the disorder if we could use gene transfer to permanently increase fetal hemoglobin levels," said Derek Persons, M.D., Ph.D., assistant member in the St. Jude Department of Hematology.

He and his colleagues developed a technique to insert the gene for gam
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A new radiation therapy treatment developed for head and neck cancer patients
2. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. MIT works toward safer gene therapy
5. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
6. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
7. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
8. Safe and effective therapy discovered for patients with protein-losing enteropathy
9. Ireland Cancer Center researchers advance stem cell gene therapy
10. Dolphin therapy a dangerous fad, Emory researchers warn
11. Cancer and arthritis therapy may be promising treatment for diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...s in the cities of Long Beach and Riverside are re...ble childhood asthma, and the true impact of air p...ely been underestimated, according to researchers ..., The study, which appears in an online edition o...ed that nine percent of all childhood asthma cases...
(Date:11/4/2009)...bacteria, it turns out, hold the power to help mil...the world clean up toxic waste on test sites. , ...ere invented back in World War II and have been us...energy compounds are often used to propel tank she... , But with increased knowledge of their environ...
(Date:11/4/2009)...homa at Norman has received more than $10 million ...art of the federal stimulus program, bringing thet...earchers to $23 million. Thirty-three projects ac...rchaeology to weather. , "The university has tho...hing areasof scholarly excellence to federal agenc...
Breaking Biology News(10 mins):USC study finds big air pollution impacts on local communities 2Genomic research will enable greener cleanup of military explosive test sites 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3LSUHSCs Kolls awarded 241 8 million to improve vaccine strategies for P carinii pneumonia 9139 1CMSA Announces Incoming President Officers and Directors 50924 1CMSA Announces Incoming President Officers and Directors 50924 2CMSA Announces Incoming President Officers and Directors 50924 3Controlling Risk Mandates Health Insurance Reviews 50921 1Controlling Risk Mandates Health Insurance Reviews 50921 2Controlling Risk Mandates Health Insurance Reviews 50921 3
...trength of the tyrannosaurid, says a University of... a fused nasal bone helped turn the animal into a ...al bones are a unique feature of tyrannosaurids," ...llow at the University of Alberta. "This adaptatio...aking their own skull while breaking the bones of ...
...ropean Union and a million in the United States su...part of their bone structure. Operations involving...ge, depend decisively on the materials used. , The...lia with the help of others, is working on the reg...odies, leaders in innovation within this specialis...
... research team led by Dr. Kyong-Tai Kim (Pohang Un...ordinated with the body,s natural sleep/wake cycle... gland in the brain, which helps to regulate our b... around which basic physiological processes procee... light and enhanced by darkness, usually peaking i...
Other Biology News:Fused nasal bones helped tyrannosaurids dismember prey 2Intelligent materials to regenerate bone tissue 2
(Date:11/5/2009)...RNewswire-FirstCall/ -- Imagenetix, Inc. (OTC Bull...encer, President and CEO of Imagenetix, will be pr...MICRO Conference on Thursday, December 3rd, at 10:... About LD MICRO ,, LD MICRO is a by-invitation ...valued companies in the micro-cap space. Since 200...
(Date:11/5/2009)...hursday, November 5, 2009 at 4:30 p.m. Eastern Tim...ire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (...ay reported unaudited financial results for the th...09 and reviewed the Company,s highlights for the t...ated results reflect the operations of OncoGenex T...
(Date:11/5/2009)... 5 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/5/2009)...ov. 5 Wound Management T... has entered into a Letter of Intent to purchase a...hnologies, Inc. (OTC Bulletin Board: VHGI). The de... and debt, 4,000,000 shares of WNDM and a royalty ...riscrip technology being acquired from VHGI. WND...
Breaking Biology Technology:Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...Wis., March 25 Plexus Corp. (Nasdaq:,PLXS), today...quarter,results for the period ended March 29, 200...closes. Senior management will host a live webcast...sday, April 24th at 8:30 a.m.,Eastern Time., Wh...ce Call, When: Thursday, April 24th at 8:30 ...
... April 24 /PRNewswire/ - SimBioSys, a leader in th... announced it has exploited parallel,computer arch...irtual,screening and docking. This advance positiv...orm virtual screening calculations., Through port...on the,IBM(R) BladeCenter(R) QS2 based on the mult...
...M, N.C. -- Duke University chemists have found a w...ms thick in very large numbers, removing a major r.... , These single-walled carbon nanotubes also fo...ss each other to potentially impede electronic per...Jie Liu, who leads the research. Carbon nanotubes ...
Other Biology Technology:Plexus Q2 Earnings Release on April 23rd After Market Close and Conference Call on April 24th at 8:30 am E.T. 2SimBioSys Utilizes Revolutionary Hardware Technology to Open New Frontiers in Molecular Modeling 2Nanotubes grown straight in large numbers 2Nanotubes grown straight in large numbers 3
SVT3-2 Diverter Valve from Bio-Rad
...he PROTEAN II xi multi-cell is for 2-D separations...ooling capabilities. The PROTEAN II xi multi-cell ...th, comb, type of glass plates, and cooling system...ed to the PROTEAN II XL multi-cell for a wider for...
PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
CleanCut Agarose, 2%, 12 ml from Bio-Rad
Biology Products: